|Application:||Gene expression microarray analysis|
|Number of samples:||320|
|Release date:||Jul 19 2018|
|Last update date:||Oct 29 2018|
|Dataset link||Innate immune activity differentiate subtypes in new onset Type 1 diabetes that predict duration of the post-onset partial remission and correlate with responsiveness to CTLA4-Ig treatment|
UPN727 cells were stimulated with CTLA4 treated patients (n=54) and placebo patients (n=20) plasma at baseline (BL), 3 month, 12 month and 24 month (total n=294 samples w/ 2 missing 3 month samples). Plus stimulated with our local Recent onset T1DM plasma (n=26). Gene expression analysis was perfromed in order to evaluate the transcriptional signature associated with T1D.